Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and toll-like receptor 2 knockout mice and protects against reinfection

Infection and Immunity

Volumn 75, Issue 12, 2007, Pages 5845-5858

  Ochoa Repáraz, Javier ^a   Sentissi, Jami ^a   Trunkle, Theresa ^a   Riccardi, Carol ^a   Pascual, David W ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BAGG ALBINO MOUSE; CONTROLLED STUDY; COXIELLA BURNETII; CYTOKINE PRODUCTION; FEMALE; FEVER; FLU LIKE SYNDROME; HOST PATHOGEN INTERACTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION RESISTANCE; INNATE IMMUNITY; KNOCKOUT MOUSE; LYMPHOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; Q FEVER; RECTUM TEMPERATURE; REINFECTION; SPLEEN WEIGHT;

ANIMALS; B-LYMPHOCYTES; BACTERIAL VACCINES; CERCOPITHECUS AETHIOPS; COXIELLA BURNETII; CYTOKINES; FEMALE; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; Q FEVER; SPLENOMEGALY; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; VACCINES, ATTENUATED; VERO CELLS;

EID: 36749068317     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00901-07     Document Type: Article

References (53)

1. Anderson, A. D., B. Smoak, E. Shuping, C. Ockenhouse, and B. Petruccelli. 2005. Q fever and the US military. Emerg. Infect. Dis. 11:1320-1322.
2. Andoh, M., T. Naganawa, A. Hotta, T. Yamaguchi, H. Fukushi, T. Masegi, and K. Hirai. 2003. SCID mouse model for lethal Q fever. Infect. Immun. 71:4717-4723.
3. Andoh, M., K. E. Russell-Lodrigue, G. Zhang, and J. E. Samuel. 2005. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice. Ann. N. Y. Acad. Sci. 1063:167-170.
4. Arricau-Bouvery, N., and A. Rodolakis. 2005. Is Q fever an emerging or re-emerging zoonosis? Vet. Res. 36:327-349.
5. Bohnet, S. G., T. R. Traynor, J. A. Majde, B. Kacsoh, and J. M. Krueger. 2004. Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2′,5′-oligoadenylate synthetase expression. Brain Res. 1027:117-125.
6. Brennan, R. E., K. Russell, G. Zhang, and J. E. Samuel. 2004. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72:6666-6675.
7. Capo, C., A. Moynault, Y. Collette, D. Olive, E. J. Brown, D. Raoult, and J. L. Mege. 2003. Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J. Immunol. 170:4217-4225.
8. Cardenosa, N., I. Sanfeliu, B. Font, T. Munoz, M. M. Nogueras, and F. Segura. 2006. Seroprevalence of human infection by Coxiella burnetii in Barcelona (northeast of Spain). Am. J. Trop. Med. Hyg. 75:33-35.
9. Coleman, S. A., E. R. Fischer, D. Howe, D. J. Mead, and R. A. Heinzen. 2004. Temporal analysis of Coxiella burnetii morphological differentiation. J. Bacteriol. 186:7344-7352.
10. Dellacasagrande, J., C. Capo, D. Raoult, and J. L. Mege. 1999. IFN-γ-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J. Immunol. 162:2259-2265.
11. Dellacasagrande, J., E. Ghigo, D. Raoult, C. Capo, and J. L. Mege. 2002. IFN-γ-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. J. Immunol. 169:6309-6315.
12. Denison, A. M., R. F. Massung, and H. A. Thompson. 2007. Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii. FEMS Microbiol. Lett. 267:102-107.
13. Faix, D., D. Harrison, and M. Riddle. 2006. Outbreak of Q fever among US military in western Iraq, June-July 2005, p. 151. Abstr. Int. Conf. Emerg. Infect. Dis., 19 to 22 March 2006, Atlanta, GA.
14. Garni, A. S., V. S. Antonios, R. L. Thompson, H. P. Chaliki, and N. M. Ammash. 2004. Q fever endocarditis in the United States. Mayo Clin. Proc. 79:253-257.
15. Ghigo, E., C. Capo, C. H. Tung, D. Raoult, J. P. Gorvel, and J. L. Mege. 2002. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-γ mediates its restoration and bacterial killing. J. Immunol. 169:4488-4495.
16. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937-945.
17. Honstettre, A., E. Ghigo, A. Moynault, C. Capo, R. Toman, S. Akira, O. Takeuchi, H. Lepidi, D. Raoult, and J. L. Mege. 2004. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J. Immunol. 172:3695-3703.
18. Hoover, T. A., D. W. Culp, M. H. Vodkin, J. C. Williams, and H. A. Thompson. 2002. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain. Infect. Immun. 70:6726-6733.
19. Howe, D., J. Melnicakova, I. Barak, and R. A. Heinzen. 2003. Fusogenicity of the Coxiella burnetii parasitophorous vacuole. Ann. N. Y. Acad. Sci. 990:556-562.
20. Jover-Diaz, F., J. Robert-Gates, L. Andreu-Gimenez, and J. Merino-Sanchez. 2001. Q fever during pregnancy: an emerging cause of prematurity and abortion. Infect. Dis. Obstet. Gynecol. 9:47-49.
21. Karakousis, P. C., M. Trucksis, and J. S. Dumler. 2006. Chronic Q fever in the United States. J. Clin. Microbiol. 44:2283-2287.
22. Kovacova, E., and J. Kazar. 2002. Q fever - still a query and underestimated infectious disease. Acta Virol. 46:193-210.
23. Leung-Shea, C., and P. J. Danaher. 2006. Q fever in members of the United States armed forces returning from Iraq. Clin. Infect. Dis. 43:e77-e82.
24. Maurin, M., and D. Raoult. 1999. Q fever. Clin. Microbiol. Rev. 12:518-553.
25. McQuiston, J. H., R. C. Holman, C. L. McCall, J. E. Childs, D. L. Swerdlow, and H. A. Thompson. 2006. National surveillance and the epidemiology of human Q fever in the United States, 1978-2004. Am. J. Trop. Med. Hyg. 75:36-40.
26. Mege, J. L., M. Maurin, C. Capo, and D. Raoult. 1997. Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism. FEMS Microbiol. Rev. 19:209-217.
27. Mege, J. L., S. Meghan, A. Honstettre, C. Capo, and D. Raoult. 2006. The two faces of interleukin 10 in human infectious diseases. Lancet Infect. Dis. 6:557-569.
28. Meghari, S., A. Honstettre, H. Lepidi, B. Ryffel, D. Raoult, and J. L. Mege. 2005. TLR2 is necessary to inflammatory response in Coxiella burnetii infection. Ann. N. Y. Acad. Sci. 1063:161-166.
29. Ochoa-Repáraz, J., C. Riccardi, A. Rynda, S. Jun, G. Callis, and D. W. Pascual. 2007. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. 178:1791-1799.
30. Parker, N. R., J. H. Barralet, and A. M. Bell. 2006. Q fever. Lancet 367:679-688.
31. Pascual, D. W., T. Trunkle, and J. Sura. 2002. Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages. Infect. Immun. 70:4273-4281.
32. Raoult, D., F. Fenollar, and A. Stein. 2002. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch. Intern. Med. 162:701-704.
33. Raoult, D., and T. Marrie. 1995. Q fever. Clin. Infect. Dis. 20:489-495.
34. Rotz, L. D., A. S. Khan, S. R. Lillibridge, S. M. Ostroff, and J. M. Hughes. 2002. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8:225-230.
35. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J. Immunol. 161:360-366.
36. Saia, R. S., and E. C. Carnio. 2006. Thermoregulatory role of inducible nitric oxide synthase in lipopolysaccharide-induced hypothermia. Life Sci. 79:1473-1478.
37. Stein, A., C. Louveau, H. Lepidi, F. Ricci, P. Baylac, B. Daroust, and D. Raoult. 2005. Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection. Infect. Immun. 73:2469-2477.
38. Toman, R., and L. Skultety. 1996. Structural study on a lipopolysaccharide from Coxiella burnetii strain Nine Mile in avirulent phase II. Carbohydr. Res. 283:175-185.
39. Traynor, T. R., J. A. Majde, S. G. Bohnet, and J. M. Krueger. 2006. Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus. Brain Behav. Immun. 20:290-299.
40. Tujulin, E., B. Lilliehook, A. Macellaro, A. Sjostedt, and L. Norlander. 1999. Early cytokine induction in mouse P388D1 macrophages infected by Coxiella burnetii. Vet. Immunol. Immunopathol. 68:159-168.
41. Turco, J., H. A. Thompson, and H. H. Winkler. 1984. Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect. Immun. 45:781-783.
42. Van Bogaert, M. J. V., L. Groenink, R. S. Oosting, K. G. C. Westphal, J. van der Gugten, and B. Olivier. 2006. Mouse strain differences in autonomic responses to stress. Genes Brain Behav. 5:139-149.
43. VanCott, J. L., S. N. Chatfield, M. Roberts, D. M. Hone, E. Hohmann, D. W. Pascual, M. Yamamoto, S. Yamamoto, H. Kiyono, and J. R. McGhee. 1998. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4:1247-1252.
44. Van Reeth, K. 2000. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74:109-116.
45. Waag, D. M., M. J. England, R. F. Tammariello, W. R. Byrne, P. Gibbs, C. M. Banfield, and M. L. Pitt. 2002. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20:2623-2634.
46. Wang, X., D. M. Hone, A. Haddad, M. T. Shata, and D. W. Pascual. 2003. M cell DNA vaccination for CTL immunity to HIV. J. Immunol. 171:4717-4725.
47. Warn, P. A., M. W. Brampton, A. Sharp, G. Morrissey, N. Steel, D. W. Denning, and T. Priest. 2003. Infrared body temperature measurement of mice as an early predictor of death in experimental fungal infections. Lab. Anim. 37:126-131.
48. Williams, J. C. (ed.). 1991. Q fever: the biology of Coxiella burnetii. CRC Press, Boca Raton, FL.
49. Yang, X., B. J., Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, R. Avci, and D. W. Pascual. 2007. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178:1059-1067.
50. Zamboni, D. S. 2004. Genetic control of natural resistance of mouse macrophages to Coxiella burnetii infection in vitro: macrophages from restrictive strains control parasitophorous vacuole maturation. Infect. Immun. 72:2395-2399.
51. Zamboni, D. S., M. A. Campos, A. C. Torrecilhas, K. Kiss, J. E. Samuel, D. T. Golenbock, F. N. Lauw, C. R. Roy, I. C. Almeida, and R. T. Gazzinelli. 2004. Stimulation of Toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection. J. Biol. Chem. 279:54405-54415.
52. Zamboni, D. S., R. A. Mortara, E. Freymuller, and M. Rabinovitch. 2002. Mouse resident peritoneal macrophages partially control in vitro infection with Coxiella burnetii phase II. Microbes Infect. 4:591-598.
53. Zamboni, D. S., and M. Rabinovitch. 2003. Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect. Immun. 71:1225-1233.